Generic medicine’s share in Pharma to be more
than 50%: Dr. Mansukh Mandaviya
Indian Medical Devices sector to play an important
role in achieving Atmanirbhar Bharat mission: Shri
Bhagwanth Khuba
 India’s 1
st ever MedTech Expo to be held from 17th
to 19th August in
Gandhinagar, Gujarat
Underlining the intent of the Central Government under the leadership of Hon’ble Prime
Minister Shri Narendra Modi, Dr. Mansukh Mandaviya, Hon’ble Union Minister for Health &
Family Welfare and Chemicals & Fertilizers, Government of India today said that India is set to
emerge as the global manufacturing hub for medical devices through a holistic development of
healthcare, pharmaceuticals and medical devices sectors. The market size of Indian medical
devices sector is likely to reach $ 50 billion in coming years from current $ 11 billion. He further
emphasized that in order to make healthcare affordable, the government is targeting to
increase the share of generic medicines to 50-60 per cent from current level of 14 per cent
alongside localization of medical devices.
Addressing the Curtain Raiser of ‘India MedTech Expo 2023’, scheduled to be held in
Gandhinagar, Gujarat from 17th to 19th August 2023, Dr Mandaviya said, “The medical device
sector is considered as one of the sunrise sectors in the country. While earlier, we used to think
in silos, Hon’ble Prime Minister Modi Ji’s holistic thinking has put India on the path of being the
global hub for manufacturing medical devices and producing innovative medical technologies.

We are also working towards making healthcare affordable and accessible for all by
popularizing and increasing share of generic medicines to 50-60 per cent.”
Outlining the government’s thinking, Mr Bhagwanth Khuba, Hon’ble Minister of State for
Chemicals & Fertilizers and New & Renewable Energy, Govt of India said, “The government is
working on mission mode to fulfil Hon’ble PM Modi’s dream of Atmanirbhar Bharat and Indian
medical devices sector will play a crucial role in it. The government is committed to supporting
the growth of the medical devices sector in the country. India also has a lot of potential in the
health tourism sector with immense opportunities and India MedTech Expo 2023 will further
add value to this vision.”
Briefing on the ministry’s initiatives for the sector, Ms S. Aparna, Secretary, Department of
Pharmaceuticals, Ministry of Chemicals & Fertilizers, Government of India said, “The
government is working to support the medical devices sector by initiating various reforms and
policies including PLI scheme for domestic manufacturing and financial support for R&D and we
are open to ideas and suggestions to help localized production.”
Representing industry’s voice, Mr Shailesh K Pathak, Secretary General, FICCI said, “As an
industry body with 96 years of legacy, we hope to see a bright future for the medical devices
sector to grow many times in the coming years. The upcoming India MedTech Expo 2023 event
will help accelerate this change.”
Mr Ravindra Pratap Singh, Joint Secretary (Policy), Department of Pharmaceuticals, Ministry of
Chemicals & Fertilizers, Government of India delivered the vote of thanks.
 231 delegates of 50 countries from ASEAN, Africa, CIS, Middle East, OSEANA
to join mega conclave;
 400+ exhibitors including MSMEs, domestic and international manufacturers,
start-ups, regulatory bodies, state governments and central ministries and
departments to participate;
 Experts, scientists and medical professionals from world renowned premier
institutions and Think-Tanks like IITs, IISc, AIIMSs, ICMR, CNCI, NITI Ayog,
World Bank to deliberate the road map;
 70+ innovations and 60+ R&D projects to be part of ‘Future Pavilion’ and
‘R&D’ Pavilion;
 7 states to showcase their manufacturing & investment potential;
To unleash the potential of the sector and brain-storm the path ahead, the Department of
Pharmaceuticals, Ministry of Chemicals & Fertilizers, Government of India is hosting the
pioneering ‘INDIA MEDTECH EXPO’ with central theme ‘India: The Next MedTech Global Hub’
Future of Devices, Diagnostics and Digital’, which is being organized alongside G20 Health
Ministers’ Conference

The Expo will have various pavilions, including Future Pavilion, R&D Pavilion, Start-up Pavilion,
State Pavilion, Regulators Pavilion and Make in India Showcase. More than 400 exhibitors
including 150 plus MSMEs, 150+ Domestic and International Manufacturers, Start-ups,
Regulatory agencies, State Governments and Central Departments will participate in it.
As many as 7 States – Madhya Pradesh, Tamil Nadu, Uttar Pradesh, Himachal Pradesh,
Rajasthan, Andhra Pradesh and Gujarat are setting up pavilions during the expo.
The expo will have pavilions for Innovations and R&D, wherein more than more than 30
companies will showcase new research and innovations. A separate pavilion for Start-ups will
also be there and as many as 75 Start-ups are participating in it.
Further, 7 regulatory agencies for Medical Devices Sector including Department of
Pharmaceuticals, GeM, ICMR, IPC, CDSCO, NPPA and BIS are participating in it.
In addition to that, thematic Conference Sessions will be organised during the 3-day event, with
the aim to explore boundless frontiers of knowledge, inspire innovations, and forge connections
that transcend boundaries. The Thematic Conference Sessions are created keeping aim of
achieving Vision 2047, a vision that embodies India’s aspirations for the MedTech sector, not
just within India but also as a significant contributor to the global healthcare landscape.
Through the 3-day conference, the event aims to:
 Bring together professionals, experts, and innovators from various fields to discuss the
latest advancements, challenges, and opportunities in the medical device sector.
 Renowned industry leaders and experts will share their insights and experiences, shedding
light on the current trends and prospects in the medical device domain.
 Latest regulatory guidelines and compliance requirements to ensure successful product
development and market access will be discussed among Industry leaders and Policy
makers.
 Thought-provoking discussions with industry experts, regulators, and healthcare
practitioners about the challenges and opportunities in medical device development,
regulation, and implementation.
A total of 231 foreign buyers from 50 countries primarily from 5 major regions Africa, ASEAN,
CIS, Middle East and Oceania will participate in the international buyer-seller meet. Based on
the profile, these buyers can be principally grouped into four main categories:
1. Government Officials from Ministry of Health – 55
2. Major Buyers & Importers of Medical devices and equipments -111
3. Procurement Agencies – 60
4. Medical Trade Journalists – 5

Besides Dr. Mansukh Mandaviya, other esteemed dignitaries who are likely to attend
the 3-days mega event are Shri Bhupendrabhai Rajnikant Patel, Hon’ble Chief Minister, Gujarat,
Shri BhagwanthKhuba, Hon’ble Union Minister of State for Chemicals & Fertilizers, Shri
BalvantSinh Chandansinh Rajput, Hon’ble Minister of Industry, Gujarat, Shri Rushikesh Ganesh
Bhai Patel, Ho’ble Health Minister, Gujarat, Dr V K Saraswat, Member, NITI Aayog, Dr V K Paul,
Member, NITI Aayog, Ms S Aparna, Secretary, Department of Pharmaceuticals, Ministry of
Chemicals and Fertilizers, Government of India, Shri Atul Kumar Tiwari, Secretary, Ministry of
Skill Development & Entrepreneurship, Government of India, Shri Rajesh Kumar Singh,
Secretary, Department for Promotion of Industries and Internal Trade, Government of India,
Shri T. V. Somanathan, Secretary, Department of Expenditure, Ministry of Finance, Government
of India, Shri Sudhansh Pant, Secretary, Ministry of Health & Family Welfare, Government of
India, Shri Saurabh Garg, Secretary, Department of Social Justice & Empowerment, Ministry of
Social Justice and Empowerment, Government of India, Shri Manoj Aggarwal, Additional Chief
secretary, Health & Family Welfare Department, Gujarat, Shri S Krishnan, Additional Chief
Secretary- Industries, Investment Promotion & Commerce Department, Tamil Nadu, Shri
Kamlesh Kumar Pant, Chairman, NPPA, Dr Basant Garg, Additional CEO, National Health
Authority (NHA), Shri Sanjay Kumar Shukla, Principal Secretary – Industrial Policy & Investment
Promotion, Madhya Pradesh, Shri R D Nazeem, Principal Secretary Industries, Himachal
Pradesh, Dr S Selvakumar, Principal Secretary, Department of Industries and Commerce,
Karnataka, Dr N Yuvaraj, Secretary, Industries & Commerce Department, Andhra Pradesh, Shri
Ravindra Pratap Singh, Joint Secretary, Department of Pharmaceuticals, Ministry of Chemicals
and Fertilizers, Dr Arun Vir Singh, CEO, Yamuna Expressway Industrial Development Authority,
Uttar Pradesh, Shri G.S. Naveen Kumar (IAS), Relief Commissioner, Uttar Pradesh, Dr Rajeev
Singh Raghuvanshi, Drugs Controller General (India), Shri Thiru. M. Arvind (IAS), MD, Tamil
Nadu Medical Services Corporation Ltd., Shri Jagdish, MD (IAS), Uttar Pradesh Medical Supplies
Corporation Ltd., Shri P. D Palsana (IAS), MD, Gujarat Medical Services Corporation Ltd., Smt.
Anupama Jorwal (IAS), MD, Rajasthan Medical Services Corporation Ltd., Shri D. Muralidhar
Reddy (IAS), Vice Chairman & Managing Director, Andhra Pradesh Medical Services &
Infrastructure Development Corporation, Shri Vivek H.P, Special Secretary, Department of
Health and Family Welfare, Arunachal Pradesh, Shri R Poornalingam, Consultant, World Bank,
Prof. Narendra Dixit, Chair-Centre for BioSystems Science and Engineering (BSSE), IISc
Bangalore, Dr Suchita Markan, Scientist-E, Mission In-Charge, Medical Device and Diagnostics
Mission Secretariat (MDMS), ICMR, Dr Srinivas, Director, AIIMS, New Delhi, Dr Jayanta
Chakrabarti, Director, CNCI, Kolkata, Prof Nalin Mehta, Director, NEIGRHIMS, Shillong, Dr
Jitendra Sharma, Managing Director, Andhra Pradesh MedTech Zone Ltd., Dr Pawanindra Lal,
Head of Surgery Dept. and Chairman of Division of Minimal Access Surgery, Maulana Azad
Medical College, Shri Andra Vamsi, Mission Director, Uttar Pradesh Skill Development Mission,
Prof.Manoj K Tiwari, Director, National Institute of Industrial Engineering (NITIE) Mumbai., Ms
Nivruti Rai, Managing Director & CEO, Invest India, Shri. Awadhesh Kumar Choudhary, Sr
Economic Advisor (Pricing, FDI, Coordination), Department of Pharmaceuticals, Dr Sanjay
Behari, Director, Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST),
Shri Kanwalpreet, Director, Public Procurement Division, Dept of Expenditure, Dr Angel Rajan

Singh, Additional Professor of Hospital Administration & Officer I/C Procurement,
AIIMS – New Delhi, Prof. M.V. Panduranga Rao, Theoretical Computer Science & Cyber Security,
IIT Hyderabad and many more nationally and internationally respected policy experts & makers,
sectoral professionals, researchers, scientists, industrialists etc.